Sakamoto J - Search Results

1

[Planning, administration, and management of the clinical trial based on EBM -what are key points to generate valid evidence?].

Sakamoto J, Morita S. Sakamoto J, et al. Arerugi. 2004 Apr;53(4):413-6. Arerugi. 2004. PMID: 15187485 Review. Japanese. No abstract available.

2

Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.

Morita S, Kobayashi K, Eguchi K, Matsumoto T, Shibuya M, Yamaji Y, Sakamoto J, Ohashi Y. Morita S, et al. Among authors: sakamoto j. Jpn J Clin Oncol. 2003 Sep;33(9):470-6. doi: 10.1093/jjco/hyg083. Jpn J Clin Oncol. 2003. PMID: 14594941 Clinical Trial.

3

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods.

Fukui T, Rahman M, Hayashi K, Takeda K, Higaki J, Sato T, Fukushima M, Sakamoto J, Morita S, Ogihara T, Fukiyama K, Fujishima M, Saruta T; CASE-J Study Group. Fukui T, et al. Among authors: sakamoto j. Hypertens Res. 2003 Dec;26(12):979-90. doi: 10.1291/hypres.26.979. Hypertens Res. 2003. PMID: 14717341 Free article. Review.

4

Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer.

Morita S, Toi M, Kobayashi T, Ito Y, Hozumi Y, Ohno S, Iwata H, Sakamoto J. Morita S, et al. Among authors: sakamoto j. Jpn J Clin Oncol. 2004 Feb;34(2):104-6. doi: 10.1093/jjco/hyh016. Jpn J Clin Oncol. 2004. PMID: 15067105 Clinical Trial.

5

Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy.

Morita S, Ohashi Y, Hirakawa K, Nakata B, Saji S, Sakamoto J. Morita S, et al. Among authors: sakamoto j. Jpn J Clin Oncol. 2004 Mar;34(3):159-61. doi: 10.1093/jjco/hyh031. Jpn J Clin Oncol. 2004. PMID: 15078913 Clinical Trial.

6

Physicians' reasons for not entering their patients in a randomized controlled trial in Japan.

Rahman M, Morita S, Fukui T, Sakamoto J. Rahman M, et al. Among authors: sakamoto j. Tohoku J Exp Med. 2004 Jun;203(2):105-9. doi: 10.1620/tjem.203.105. Tohoku J Exp Med. 2004. PMID: 15212145 Free article.

7

Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.

Sakamoto J, Morita S, Kodera Y, Rahman M, Nakao A. Sakamoto J, et al. Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S25-31. doi: 10.1007/s00280-004-0883-1. Cancer Chemother Pharmacol. 2004. PMID: 15309511 Review.

8

[Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module].

Morita S, Shimozuma K, Sato A, Nakamachi M, Blazeby J, West K, Fukuhara S, Sakamoto J. Morita S, et al. Among authors: sakamoto j. Gan To Kagaku Ryoho. 2004 Aug;31(8):1195-9. Gan To Kagaku Ryoho. 2004. PMID: 15332542 Japanese.

9

Physicians' attitudes towards and reasons for participation in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial.

Rahman M, Morita S, Fukui T, Sakamoto J. Rahman M, et al. Among authors: sakamoto j. J Epidemiol. 2005 Mar;15(2):38-40. doi: 10.2188/jea.15.38. J Epidemiol. 2005. PMID: 15762092 Free PMC article.

10

Quality of life in gastric cancer.

Kaptein AA, Morita S, Sakamoto J. Kaptein AA, et al. Among authors: sakamoto j. World J Gastroenterol. 2005 Jun 7;11(21):3189-96. doi: 10.3748/wjg.v11.i21.3189. World J Gastroenterol. 2005. PMID: 15929166 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,150 results

Search Page

Filters